Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03100565
Other study ID # YuzuncuYil
Secondary ID
Status Completed
Phase N/A
First received March 17, 2017
Last updated March 11, 2018
Start date September 2016
Est. completion date March 10, 2018

Study information

Verified date March 2018
Source Yuzuncu Yil University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cervical cancer is the third most common genital cancer worldwide. The diagnosis of cervical cancer is performed with the cervical biopsy which is guided by the colposcopy. The colposcopy guided cervical biopsy creates pain and several methods have been reported to overcome the pain related with this procedure. Local anesthetic agent injection into the cervix has been studied and found to be effective and also, forced coughing was compared with local anesthetic injection and it is found to be more effective. In fact local injections can create the pain by itself.However no study compared the effect of forced coughing to local anesthetic spray. The study aims to evaluate the comparison of forced coughing with local anesthetic spray with respect to perceived pain during colposcopy guided biopsy.


Recruitment information / eligibility

Status Completed
Enrollment 96
Est. completion date March 10, 2018
Est. primary completion date March 8, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with age >18,

- Presence of cervix,

- Patients who need a diagnostic work up for abnormal cervical smear results.

Exclusion Criteria:

- Pregnancy,

- Presence of already known invasive cancer,

- Allergy to anesthetic agents.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
local lidocaine spray
The lidocaine spray will be introduced to the cervix just before the biopsy procedure
Other:
forced coughing
The patients will be asked to forced coughing during the biopsy procedure

Locations

Country Name City State
Turkey Yuzuncu Yil University, Medical faculty, department of obstetric and gynecology Van

Sponsors (1)

Lead Sponsor Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain during procedure evaluated by the 0-10 cm scale of Visual analog scale (VAS) scoring system The perceived pain will be measured during the biopsy procedure. It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain'' 0-1 min
Secondary Pain at the 30th minutes after the procedure evaluated by the 0-10 cm scale of VAS scoring system The perceived pain will be measured after the biopsy procedure (at the 30th min). It will be evaluated by the 0-10 cm scale of VAS scoring system. The patient will be asked to rate her pain as 0 corresponds ''no pain'' and 10 to the '' worst pain'' 30. Min
See also
  Status Clinical Trial Phase
Recruiting NCT03701347 - A Comparison of Three Simulators for Colposcopy LEEP Training N/A
Withdrawn NCT04704011 - Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rates: The BASICS Trial N/A
Completed NCT00839475 - Investigation of the Uterine Cervix Using CervicalMD N/A
Recruiting NCT06149598 - Coughing at Time of Cervical Biopsy N/A
Completed NCT01214304 - Aromatherapy to Reduce Pain and Anxiety During Cervical Colposcopy N/A
Completed NCT03317470 - Addressing Unmet Basic Needs to Improve Adherence Among Women With an Abnormal Pap Phase 1
Recruiting NCT05281939 - Multi-center Application of an AI System for Diagnosis of Cervical Lesions Based on Colposcopy Images N/A
Completed NCT00474968 - Adequacy and Efficacy of the e2TM Cervical Cell Collector Compared to Standard Spatula/CytoBrush Technique. N/A
Completed NCT00941512 - High Resolution Digital Imaging of the Uterine Cervix N/A
Completed NCT03464552 - Celecoxib in Colposcopic Directed Biopsy Phase 4